Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as a percentage of revenue in the same period.
| Tick rows to compare them in a chart (up to 4) | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.5% | 30.5% | 30.9% | 29.4% | 31.0% | 32.6% | 19.9% | 34.9% | 40.9% | 47.2% | 32.7% | 65.9% | 48.3% | 64.3% | 165.3% | 45.7% | 49.0% | 99.1% | 71.3% | 334.8% | 35.4% | 43.6% | 373.5% | 244.8% | 62.2% | 84.9% | 71.3% | 82.5% | 96.0% | 111.5% | 209.0% | 176.1% | 141.4% | 105.9% | 98.2% | 105.8% | 181.7% | 46.3% | 41.9% | 12.4% | 24.4% | |
| 67.5% | 69.5% | 69.1% | 70.6% | 69.0% | 67.4% | 80.1% | 65.1% | 59.1% | 52.8% | 67.3% | 34.1% | 51.7% | 35.7% | -65.3% | 54.3% | 51.0% | 0.9% | 28.7% | -234.8% | 64.6% | 56.4% | -273.5% | -144.8% | 37.8% | 15.1% | 28.7% | 17.5% | 4.0% | -11.5% | -109.0% | -76.1% | -41.4% | -5.9% | 1.8% | -5.8% | -81.7% | 53.7% | 58.1% | 87.6% | 75.6% | |
| 54.0% | 59.3% | 63.1% | 63.6% | 62.5% | 79.3% | 50.0% | 85.0% | 92.9% | 138.3% | 649.6% | 141.7% | 95.9% | 136.6% | 33.7% | 38.0% | 31.1% | 43.1% | 18.7% | 295.1% | 345.6% | 373.1% | 330.6% | 214.1% | 410.6% | 75.5% | 612.2% | 657.1% | 672.0% | 840.0% | 1,058.1% | 1,337.9% | 2,188.7% | 1,193.1% | 988.1% | 757.6% | 1,342.1% | 412.7% | 146.2% | 22.9% | 112.5% | |
| 57.6% | 69.0% | 76.9% | 65.4% | 71.4% | 85.4% | 42.6% | 90.6% | 76.0% | 119.3% | 57.7% | 144.0% | 59.7% | 107.4% | 251.6% | 77.1% | 61.6% | 94.6% | 143.0% | 804.9% | 524.2% | 559.9% | 455.0% | 355.1% | 435.2% | 60.6% | 652.9% | 628.8% | 527.2% | 666.9% | 835.9% | 953.1% | 1,437.4% | 1,032.1% | 924.4% | 921.6% | 1,884.7% | 821.0% | 386.5% | 90.5% | 249.5% | |
| 111.7% | 128.3% | 140.0% | 129.0% | 133.8% | 164.6% | 92.7% | 175.6% | 168.9% | 257.6% | 707.3% | 285.6% | 155.6% | 244.0% | 646.4% | 110.0% | 89.9% | 98.5% | 10.3% | 710.4% | 751.8% | 702.4% | 320.2% | 257.0% | 867.8% | 60.6% | 1,265.1% | 1,285.9% | 1,199.2% | 1,506.8% | 1,795.6% | 2,216.2% | 8,444.1% | 2,225.2% | 2,398.1% | 1,679.2% | 3,629.1% | 1,233.7% | 532.7% | 113.4% | 372.8% | |
| -44.2% | -58.8% | -70.8% | -58.4% | -64.8% | -97.2% | -34.4% | -110.6% | -109.9% | -204.9% | -780.1% | -251.6% | -104.0% | -211.0% | -711.7% | -55.6% | -38.9% | -97.6% | 18.3% | -945.2% | -687.2% | -646.0% | -593.7% | -401.8% | -830.0% | -45.5% | -1,236.4% | -1,268.4% | -1,195.2% | -1,518.3% | -1,904.6% | -2,292.3% | -8,485.5% | -2,231.1% | -2,396.3% | -1,685.0% | -3,710.7% | -1,180.0% | -474.6% | -25.8% | -297.2% | |
| 0.5% | 0.5% | 0.2% | 0.3% | 0.3% | 0.3% | 0.1% | 0.2% | 0.3% | 12.3% | 9.9% | 18.5% | 12.1% | 19.4% | 54.3% | 15.4% | 15.1% | 19.7% | 23.6% | 132.1% | 121.4% | 143.0% | 132.6% | 37.0% | 70.9% | 12.2% | 36.1% | 17.5% | 7.7% | 0.1% | 0.6% | 0.2% | 0.3% | 0.2% | 0.5% | 0.1% | 0.0% | 30.9% | 64.9% | 12.5% | 21.4% | |
| -96.4% | -62.1% | -98.9% | -61.2% | -37.6% | -90.5% | -45.0% | -107.9% | -150.1% | -225.2% | -795.9% | -268.8% | -109.6% | -235.0% | -626.6% | -69.7% | -52.0% | -117.0% | -4.8% | -783.2% | -812.6% | -791.5% | -724.3% | -434.5% | -898.2% | -46.0% | -1,257.4% | -1,231.2% | -1,153.6% | -1,435.9% | -2,718.9% | -2,231.6% | -8,435.3% | -2,514.8% | -1,665.0% | -4,038.3% | -3,112.0% | -5,008.4% | -514.9% | -34.1% | -647.0% | |
| -1.1% | -0.9% | -1.3% | -1.0% | -1.5% | -1.8% | -0.9% | -9.3% | -2.5% | -44.1% | -4.6% | -2.5% | -1.5% | -2.2% | 8.2% | 0.1% | -0.4% | -0.2% | 0.2% | -1.5% | -1.6% | -1.8% | 0.4% | -1.1% | -3.1% | -0.3% | 0.5% | -3.0% | -3.7% | -0.4% | -27.0% | -2.7% | -235.6% | 1.3% | -7.3% | -6.5% | 0.4% | 6,125.9% | 0.1% | – | – | |
| -93.5% | -59.2% | -95.9% | -58.4% | -34.3% | -86.3% | -35.4% | -95.8% | -144.4% | -176.7% | -788.4% | -260.2% | -107.7% | -232.8% | -2,024.6% | -189.9% | -142.5% | -125.1% | -215.5% | -504.2% | -525.6% | -893.0% | -679.5% | -349.2% | -605.8% | 522.5% | -1,257.9% | -1,228.2% | -1,149.9% | -1,435.5% | -2,691.9% | -2,228.9% | -8,199.7% | -2,516.1% | -1,657.7% | -4,038.3% | -3,112.4% | -5,008.4% | -514.9% | -34.1% | -647.0% | |
| -44.2% | -49.4% | -83.7% | -47.1% | -23.5% | -72.9% | -34.1% | -88.6% | -131.0% | -187.3% | -767.6% | -222.1% | -80.5% | -170.3% | -498.4% | -38.2% | -21.2% | -77.6% | 38.6% | -547.5% | -598.8% | -546.5% | -385.8% | -358.3% | -716.6% | -22.9% | -1,123.7% | -1,121.2% | -1,050.1% | -1,316.2% | -2,586.9% | -2,081.7% | -8,212.4% | -2,443.9% | -1,609.5% | -3,991.3% | -3,180.7% | -4,950.0% | -425.0% | -16.9% | -617.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.